Repository logo
 
Publication

Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid‐beta peptide levels in vivo

2007-04Journal article Open access
Simple item page
dc.contributor.authorHIRSCH‐REINSHAGEN, V.
dc.contributor.authorCHAN, J.Y.
dc.contributor.authorWILKINSON, A.
dc.contributor.authorTANAKA, T.
dc.contributor.authorFAN, J.
dc.contributor.authorOU, G.
dc.contributor.authorMAIA, L.F.
dc.contributor.authorSINGARAJA, R.R.
dc.contributor.authorHAYDEN, M.R.
dc.contributor.authorWELLINGTON, C.L.
dc.date.accessioned2011-01-19T12:45:47Z
dc.date.available2011-01-19T12:45:47Z
dc.date.issued2007-04
dc.description.abstractJ Lipid Res. 2007 Apr;48(4):914-23. Epub 2007 Jan 18. Physiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid-beta peptide levels in vivo. Hirsch-Reinshagen V, Chan JY, Wilkinson A, Tanaka T, Fan J, Ou G, Maia LF, Singaraja RR, Hayden MR, Wellington CL. Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada. Abstract ABCA1-deficient mice have low levels of poorly lipidated apolipoprotein E (apoE) and exhibit increased amyloid load. To test whether excess ABCA1 protects from amyloid deposition, we crossed APP/PS1 mice to ABCA1 bacterial artificial chromosome (BAC) transgenic mice. Compared with wild-type animals, the ABCA1 BAC led to a 50% increase in cortical ABCA1 protein and a 15% increase in apoE abundance, demonstrating that this BAC supports modest ABCA1 overexpression in brain. However, this was observed only in animals that do not deposit amyloid. Comparison of ABCA1/APP/PS1 mice with APP/PS1 controls revealed no differences in levels of brain ABCA1 protein, amyloid, Abeta, or apoE, despite clear retention of ABCA1 overexpression in the livers of these animals. To further investigate ABCA1 expression in the amyloid-containing brain, we then compared ABCA1 mRNA and protein levels in young and aged cortex and cerebellum of APP/PS1 and ABCA1/APP/PS1 animals. Compared with APP/PS1 controls, aged ABCA1/APP/PS1 mice exhibited increased ABCA1 mRNA, but not protein, selectively in cortex. Additionally, ABCA1 mRNA levels were not increased before amyloid deposition but were induced only in the presence of extensive Abeta and amyloid levels. These data suggest that an induction of ABCA1 expression may be associated with late-stage Alzheimer's neuropathology. PMID: 17235115 [PubMed - indexed for MEDLINE]por
dc.identifier.issn0022-2275
dc.identifier.urihttp://hdl.handle.net/10400.16/519
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherAmerican Society for Biochemistry and Molecular Biologypor
dc.relation.publisherversionhttp://www.jlr.org/content/48/4/914.full.pdf+htmlpor
dc.titlePhysiologically regulated transgenic ABCA1 does not reduce amyloid burden or amyloid‐beta peptide levels in vivopor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleJournal of Lipid Researchpor
rcaap.rightsopenAccesspor
rcaap.typearticleeng

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
pdf. 10.pdf
Size:
453.14 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

SN - Artigos publicados em revistas indexadas na Pubmed/Medline